- Home
- ELAB vs PTIX Comparison
ELAB vs PTIX Comparison
Compare ELAB & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELAB
- PTIX
- Stock Information
- Founded
- ELAB 2020
- PTIX 1994
- Country
- ELAB United States
- PTIX United States
- Employees
- ELAB N/A
- PTIX N/A
- Industry
- ELAB
- PTIX Biotechnology: Pharmaceutical Preparations
- Sector
- ELAB
- PTIX Health Care
- Exchange
- ELAB Nasdaq
- PTIX Nasdaq
- Market Cap
- ELAB 3.2M
- PTIX 2.8M
- IPO Year
- ELAB 2023
- PTIX 2016
- Fundamental
- Price
- ELAB $1.98
- PTIX $2.78
- Analyst Decision
- ELAB
- PTIX
- Analyst Count
- ELAB 0
- PTIX 0
- Target Price
- ELAB N/A
- PTIX N/A
- AVG Volume (30 Days)
- ELAB 42.6K
- PTIX 104.7K
- Earning Date
- ELAB 08-13-2025
- PTIX 08-22-2025
- Dividend Yield
- ELAB N/A
- PTIX N/A
- EPS Growth
- ELAB N/A
- PTIX N/A
- EPS
- ELAB N/A
- PTIX N/A
- Revenue
- ELAB N/A
- PTIX N/A
- Revenue This Year
- ELAB N/A
- PTIX N/A
- Revenue Next Year
- ELAB N/A
- PTIX N/A
- P/E Ratio
- ELAB N/A
- PTIX N/A
- Revenue Growth
- ELAB N/A
- PTIX N/A
- 52 Week Low
- ELAB $1.81
- PTIX $2.35
- 52 Week High
- ELAB $546.00
- PTIX $15.54
- Technical
- Relative Strength Index (RSI)
- ELAB 44.44
- PTIX 41.42
- Support Level
- ELAB $1.85
- PTIX $2.60
- Resistance Level
- ELAB $2.01
- PTIX $3.24
- Average True Range (ATR)
- ELAB 0.12
- PTIX 0.27
- MACD
- ELAB -0.00
- PTIX 0.02
- Stochastic Oscillator
- ELAB 34.69
- PTIX 27.69
About ELAB Elevai Labs Inc.
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.